Ototoxic drugs, diagnosis and monitoring

dc.authorscopusid10144697600
dc.authorscopusid55539427200
dc.contributor.authorToplu Y.
dc.contributor.authorTan M.
dc.date.accessioned2024-08-04T20:04:06Z
dc.date.available2024-08-04T20:04:06Z
dc.date.issued2019
dc.departmentİnönü Üniversitesien_US
dc.description.abstractOtotoxicity is a cochlear or vestibular dysfunction caused by chemical, physical or biological effects. It affects the internal ear and hearing nerve and might be reversible or irreversible. Besides hearing loss, it can also cause tinnitus or dizziness. In practice, drug-induced ototoxicity is in the foreground. Ototoxic drugs have harmful effects on the cochlea and the vestibular system. When the cochlea is affected, it may result in hearing dysfunction. When the vestibular system is affected, it may result in vertigo. Although ototoxic drugs have harmful effects, they must be used in clinical practices. Aminoglycoside antibiotics, loop diuretics, platinum-based chemotherapeutic agents, macrolide antibiotics and antimalarial are among the 600 frequently used ototoxic drugs. The ototoxic drugs cause a wide range of symptoms on the auditory system. Otological problems can be hearing loss, tinnitus, hyperacusis, aural fullness, dizziness and vertigo. The degree of these symptoms may vary between patients. The symptoms may occur together, individually, gradually or rapidly. The most important symptom is hearing loss which is not life-threatening; however, it significantly decreases the quality of life. It also impairs communication with the environment. The most important step in ototoxicity is the diagnosis and the first step of the diagnosis is to think of ototoxicity. The diagnosis is made based on anamnesis, symptoms and audiological test results. High frequency audiometry, distortion product of otoacoustic emissions (DPOAEs) and tympanometry can be performed as audiological tests. The results of these tests must be compared before and after drug use. Nowadays, ototoxicity can be prevented with close monitoring and follow-up during the use of ototoxic drugs. If hearing loos is diagnosed during treatment, the treatment must be reevaluated. In the case of permanent hearing loss, options such as hearing aids and cochlear implants can be considered. © 2019 by Nova Science Publishers, Inc. All rights reserved.en_US
dc.identifier.endpage49en_US
dc.identifier.isbn9781536164176
dc.identifier.isbn9781536163964
dc.identifier.scopus2-s2.0-85077536791en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage27en_US
dc.identifier.urihttps://hdl.handle.net/11616/92353
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherNova Science Publishers, Inc.en_US
dc.relation.ispartofOtotoxicity: Signs, Symptoms and Treatmenten_US
dc.relation.publicationcategoryKitap Bölümü - Uluslararasıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAudiological testsen_US
dc.subjectMonitoringen_US
dc.subjectOtotoxicityen_US
dc.titleOtotoxic drugs, diagnosis and monitoringen_US
dc.typeBook Chapteren_US

Dosyalar